Meet our compounding defenders (and guardians and champions)
A few weeks ago, we offered you a deal. Since then, several of you have taken us up on it — so here’s a big thank you to our Package Deal investors.
A few weeks ago, we offered you a deal. Since then, several of you have taken us up on it — so here’s a big thank you to our Package Deal investors.
APC’s Jen Petska is the featured guest on the latest CPhT Connect podcast, “the only weekly podcast specifically for pharmacy technicians.” Give a listen.
This piece is appalling – both the bias and error in the article itself AND that Pharmacy Times would take a swipe at a legitimate pharmacy practice like pharmacy compounding.
APC may soon be coming to a city near you — and we’d love to meet up. We’ll be in the Tampa/St. Pete area on June 12 for our next CompoundED UpDATE — part of a series of regional meetings made possible by a grant from PCCA.
Drugmakers, newsmedia, and even regulators have been wrongly conflating legitimate compounding of GLP-1s with illegal online drug sales. In their latest RogueRx Activity Report, NABP doesn’t make that mistake.
A recent study published in JAMA suggests that the benefits of hormone therapy outweigh the risks for treating menopause symptoms, particularly among women under 60.
This week, APC submitted a comment letter to the Massachusetts Board of Pharmacy about two issues on which the Board recently expressed concern.
This week, APC wrote to state boards of pharmacy and FDA to make them aware of delays in completing stability studies as USP 797 is enforced across the country.
Wells Pharmacy Network is our newest Bronze-level Corporate Patron — a $10,000 investment.
You know this by now: You can’t believe everything you read in the news, especially when it comes to compounding.